Ascendis Pharma A (ASND) Net Margin Growth (3y) (2017 - 2026)
Ascendis Pharma A (ASND) Net Margin Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9,283.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 506.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -569.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 6,537.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Ascendis Pharma A | 15.31 Bn | 14.64 Bn | 268.20 Mn | 58,900.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 58,900.00 |
| Dec 31, 2025 | 89,778.00 |
| Sep 30, 2025 | 109,015.00 |
| Jun 30, 2025 | 130,693.00 |
| Mar 31, 2025 | 174,418.00 |
| Dec 31, 2024 | 11,073.00 |
| Sep 30, 2024 | -739,057.00 |
| Jun 30, 2024 | -1.28 Mn |
| Mar 31, 2024 | 855,380.00 |
| Dec 31, 2023 | 98,232.00 |
| Sep 30, 2023 | 408,070.00 |
| Jun 30, 2023 | -636,273.00 |
| Mar 31, 2023 | -317,826.00 |
| Dec 31, 2022 | -2,661.00 |
| Sep 30, 2022 | -223,905.00 |
| Jun 30, 2022 | -318,535.00 |
| Mar 31, 2022 | -84,728.00 |
| Dec 31, 2021 | 867.00 |
| Sep 30, 2021 | 721,922.00 |
| Jun 30, 2021 | 13.97 Mn |